Patients squeezed in fight over who gets to bill for pricey infusion drugs

FHS
July 5, 2023
10:36 am

Health insurers and medical providers are battling over who should supply high-cost infusion drugs for patients, with the tussle over profits now spilling into statehouses across the country.

Exclusive: Autoimmune CAR-T biotech Kyverna Therapeutics is considering an IPO next month

Kyverna Therapeutics, one of the clinical-stage biotechs at the forefront of CAR-T cell therapy’s expansion into autoimmune diseases, is considering an IPO as early as

January 13, 2024

Spine volumes to grow 6.5% next year as post-pandemic boost continues: analysts

Dive Brief: U.S. spine surgeons expect procedure volumes to increase by 6.5% over the next year, suggesting companies such as Medtronic and Johnson & Johnson

September 1, 2023

H.E.L Group expands into new purpose-designed facilities

Bespoke lab and office space designed to foster innovation and collaboration with colleagues and customers.

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.